Julia M. Gomez-Martinez

Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Safety of Multi-Omics-Guided Therapy in Advanced Melanoma: A Matched Comparative Cohort Analysis.

Safety of Multi-Omics-Guided Therapy in Advanced Melanoma: A Matched Comparative Cohort Analysis.

Journal: JCO precision oncology

Published: February 25, 2026

Targeting the tumor cell-intrinsic ITGB2 axis inhibits melanoma progression.

Targeting the tumor cell-intrinsic ITGB2 axis inhibits melanoma progression.

Journal: Molecular cancer

Published: June 03, 2025

Combination of the Novel RAF Dimer Inhibitor Brimarafenib With the MEK Inhibitor Mirdametinib Is Effective Against NRAS Mutant Melanoma.

Combination of the Novel RAF Dimer Inhibitor Brimarafenib With the MEK Inhibitor Mirdametinib Is Effective Against NRAS Mutant Melanoma.

Journal: Pigment cell & melanoma research

Published: May 12, 2025

HLA export by melanoma cells decoys cytotoxic T cells to promote immune evasion.

HLA export by melanoma cells decoys cytotoxic T cells to promote immune evasion.

Journal: Cell

Published: January 08, 2025

18 F-FDG PET/CT for Detection of Immunotherapy-Induced Hypophysitis-A Case-Control Study.

18 F-FDG PET/CT for Detection of Immunotherapy-Induced Hypophysitis-A Case-Control Study.

Journal: Clinical nuclear medicine

Published: September 26, 2024

The serum metabolome serves as a diagnostic biomarker and discriminates patients with melanoma from healthy individuals.

The serum metabolome serves as a diagnostic biomarker and discriminates patients with melanoma from healthy individuals.

Journal: Cell reports. Medicine

Published: July 08, 2024

Real-World Data on Clinical Outcomes and Treatment Management of Advanced Melanoma Patients: Single-Center Study of a Tertiary Cancer Center in Switzerland.

Real-World Data on Clinical Outcomes and Treatment Management of Advanced Melanoma Patients: Single-Center Study of a Tertiary Cancer Center in Switzerland.

Journal: Cancers

Published: January 31, 2024

Temporal genomic analysis of homogeneous tumor models reveals key regulators of immune evasion in melanoma.

Temporal genomic analysis of homogeneous tumor models reveals key regulators of immune evasion in melanoma.

Journal: Cancer discovery

Published: November 29, 2023

Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma.

Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma.

Journal: Cancer discovery

Published: November 29, 2023

Myeloid-T cell interplay and cell state transitions associated with checkpoint inhibitor response in melanoma.

Myeloid-T cell interplay and cell state transitions associated with checkpoint inhibitor response in melanoma.

Journal: Med (New York, N.Y.)

Published: June 14, 2023

Proteomic Profiling of Advanced Melanoma Patients to Predict Therapeutic Response to Anti-PD-1 Therapy.

Proteomic Profiling of Advanced Melanoma Patients to Predict Therapeutic Response to Anti-PD-1 Therapy.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 01, 2023

Swiss public health measures associated with reduced SARS-CoV-2 transmission using genome data.

Swiss public health measures associated with reduced SARS-CoV-2 transmission using genome data.

Journal: Science translational medicine

Published: November 08, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026